Literature DB >> 15869672

Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model.

Li Wang1, Stuart Lahtinen, Linnea Lentz, Nancy Rakow, Cameron Kaszas, Linda Ruetz, Lee Stylos, Walter H Olson.   

Abstract

BACKGROUND: Noninvasive measures of impedance reflect alterations in thoracic fluid and pulmonary edema in acute animal and human studies.
MATERIALS AND METHODS: We evaluated the feasibility of using an implantable impedance measuring device and cardiac lead system to monitor intrathoracic congestion in a pacing-induced heart failure canine model. Three devices were implanted in each of five dogs: a modified pacemaker to measure impedance from a defibrillation lead implanted in the right ventricle; an implantable hemodynamic monitoring device to measure left ventricular end diastolic pressure (LVEDP) and a second pacemaker to deliver rapid (240 pulses per minute) ventricular pacing to induce heart failure.
RESULTS: All five dogs developed severe heart failure after 3-4 weeks of rapid pacing and recovered following pacing termination. The LVEDP increased and impedance decreased during pacing-induced heart failure and recovered after pacing cessation. At the end of pacing, there was a mean impedance reduction of 10.6 +/- 8.3% and a mean LVEDP increase of 18.1 +/- 4.5 mmHg compared to baseline. The impedance and LVEDP were inversely correlated (r =-0.41 to -0.85, all P < 0.05).
CONCLUSIONS: In the canine model, measurement of chronic intrathoracic impedance with an implantable system effectively revealed changes in thoracic congestion due to heart failure reflected by LVEDP. These data suggest that implantable device-based impedance measurement merits further investigation as a tool to monitor the fluid status of heart failure patients.

Entities:  

Mesh:

Year:  2005        PMID: 15869672     DOI: 10.1111/j.1540-8159.2005.40009.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  16 in total

1.  Left ventricular epicardial admittance measurement for detection of acute LV dilation.

Authors:  John E Porterfield; Erik R Larson; James T Jenkins; Daniel Escobedo; Jonathan W Valvano; John A Pearce; Marc D Feldman
Journal:  J Appl Physiol (1985)       Date:  2010-12-09

Review 2.  Implantable cardiac resynchronization therapy devices to monitor heart failure clinical status.

Authors:  Jeffrey Wing-Hong Fung; Cheuk-Man Yu
Journal:  Curr Heart Fail Rep       Date:  2007-03

Review 3.  Role of Monitoring Devices in Preventing Heart Failure Admissions.

Authors:  Kenneth McDonald; Mark Wilkinson; Mark Ledwidge
Journal:  Curr Heart Fail Rep       Date:  2015-08

Review 4.  Bioimpedance to prevent heart failure hospitalization.

Authors:  Nancy M Albert
Journal:  Curr Heart Fail Rep       Date:  2006-09

5.  Feasibility of using multivector impedance to monitor pulmonary congestion in heart failure patients.

Authors:  Philip F Binkley; James G Porterfield; Linda M Porterfield; Scott L Beau; Raffaele Corbisiero; G Stephen Greer; Charles J Love; Melanie Turkel; Anders Bjorling; Fujian Qu; Taraneh G Farazi
Journal:  J Interv Card Electrophysiol       Date:  2012-06-12       Impact factor: 1.900

6.  Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors.

Authors:  Dirar S Khoury; Mihir Naware; Jeff Siou; Andreas Blomqvist; Nilesh S Mathuria; Jianwen Wang; Hue-Teh Shih; Sherif F Nagueh; Dorin Panescu
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

7.  Monitoring of heart failure: comparison of left atrial pressure with intrathoracic impedance and natriuretic peptide measurements in an experimental model of ovine heart failure.

Authors:  Miriam T Rademaker; Christopher J Charles; Iain C Melton; A Mark Richards; Christopher M Frampton; Jeff Siou; Fujian Qu; Neal L Eigler; Dan Gutfinger; Richard W Troughton
Journal:  Clin Sci (Lond)       Date:  2011-03       Impact factor: 6.124

8.  Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case-control study.

Authors:  Massimiliano Maines; Domenico Catanzariti; Claudio Cemin; Chiara Vaccarini; Giuseppe Vergara
Journal:  J Interv Card Electrophysiol       Date:  2007-09-06       Impact factor: 1.900

Review 9.  Leveraging cardiac resynchronization therapy devices to monitor patients with heart failure.

Authors:  Jeffrey Wing-Hong Fung; Cheuk-Man Yu
Journal:  Curr Heart Fail Rep       Date:  2008-03

Review 10.  The role of non-invasive devices for the telemonitoring of heart failure patients.

Authors:  A Faragli; D Abawi; C Quinn; M Cvetkovic; T Schlabs; E Tahirovic; H-D Düngen; B Pieske; S Kelle; F Edelmann; Alessio Alogna
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.